G1 Therapeutics (GTHX) FCF/share US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| FCF/share, rub | -2.73 | -2.21 | -3.15 | -2.96 | -0.74 | -0.72 | |||
| Changes by years, y/y, % | +21% | -19% | +42% | -6% | -75% | -19.9% | |||
G1 Therapeutics. FCF/share, rub
G1 Therapeutics. FCF/share, changes, %
G1 Therapeutics (GTHX) FCF/share US GAAP (quarter values) |
||||||||
| FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | LTM ? | |||
| FCF/share, rub | 0.27 | -0.20 | -0.25 | -0.17 | -0.10 | -0.72 | ||
| Changes by years, y/y, % | -130% | -59% | -63% | -70% | -137% | |||
| Changes by quarters, q/q, % | -148% | -175% | +21% | -31% | -41% | |||